The efficacy and safety of selumetinib as secondary therapy for late-stage and metastatic non-small cell lung cancer: results from a systematic review and meta-analysis
@article{ATM95635,
author = {Wei-Wei Wang and Wei-Qi Wang and Shan-Shan Wang and Lei Pan},
title = {The efficacy and safety of selumetinib as secondary therapy for late-stage and metastatic non-small cell lung cancer: results from a systematic review and meta-analysis},
journal = {Annals of Translational Medicine},
volume = {10},
number = {10},
year = {2022},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/95635}
}